Molin D - Search Results

1

Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma.

Molin D, Edström A, Glimelius I, Glimelius B, Nilsson G, Sundström C, Enblad G. Molin D, et al. Br J Haematol. 2002 Oct;119(1):122-4. doi: 10.1046/j.1365-2141.2002.03768.x. Br J Haematol. 2002. PMID: 12358914

2

VEGF: a modifier of the del22q11 (DiGeorge) syndrome?

Stalmans I, Lambrechts D, De Smet F, Jansen S, Wang J, Maity S, Kneer P, von der Ohe M, Swillen A, Maes C, Gewillig M, Molin DG, Hellings P, Boetel T, Haardt M, Compernolle V, Dewerchin M, Plaisance S, Vlietinck R, Emanuel B, Gittenberger-de Groot AC, Scambler P, Morrow B, Driscol DA, Moons L, Esguerra CV, Carmeliet G, Behn-Krappa A, Devriendt K, Collen D, Conway SJ, Carmeliet P. Stalmans I, et al. Among authors: molin dg. Nat Med. 2003 Feb;9(2):173-82. doi: 10.1038/nm819. Epub 2003 Jan 21. Nat Med. 2003. PMID: 12539040

3

Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease.

Molin D, Fischer M, Xiang Z, Larsson U, Harvima I, Venge P, Nilsson K, Sundström C, Enblad G, Nilsson G. Molin D, et al. Br J Haematol. 2001 Sep;114(3):616-23. doi: 10.1046/j.1365-2141.2001.02977.x. Br J Haematol. 2001. PMID: 11552987

4

The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease.

Molin D, Glimelius B, Sundström C, Venge P, Enblad G. Molin D, et al. Leuk Lymphoma. 2001 Jul;42(3):457-65. doi: 10.3109/10428190109064602. Leuk Lymphoma. 2001. PMID: 11699410

5

Thymidylate synthase and p53 expression in primary tumor do not predict chemotherapy outcome in metastatic colorectal carcinoma.

Berglund A, Edler D, Molin D, Nordlinder H, Graf W, Glimelius B. Berglund A, et al. Among authors: molin d. Anticancer Res. 2002 Nov-Dec;22(6B):3653-9. Anticancer Res. 2002. PMID: 12552972

6

Early and intermediate stage Hodgkin's lymphoma--report from the Swedish National Care Programme.

Molin D, Enblad G, Gustavsson A, Ekman T, Erlanson M, Haapaniemi E, Glimelius B; Swedish National Care Programme; Swedish Lymphoma Study Group. Molin D, et al. Eur J Haematol. 2003 Mar;70(3):172-80. doi: 10.1034/j.1600-0609.2003.00030.x. Eur J Haematol. 2003. PMID: 12605661

7

Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma.

Fischer M, Bijman M, Molin D, Cormont F, Uyttenhove C, van Snick J, Sundström C, Enblad G, Nilsson G. Fischer M, et al. Among authors: molin d. Leukemia. 2003 Dec;17(12):2513-6. doi: 10.1038/sj.leu.2403123. Leukemia. 2003. PMID: 14562126

8

Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB.

Glimelius I, Molin D, Amini RM, Gustavsson A, Glimelius B, Enblad G. Glimelius I, et al. Among authors: molin d. Eur J Haematol. 2003 Nov;71(5):327-33. doi: 10.1034/j.1600-0609.2003.00108.x. Eur J Haematol. 2003. PMID: 14667195

9

Bystander cells and prognosis in Hodgkin lymphoma. Review based on a doctoral thesis.

Molin D. Molin D. Ups J Med Sci. 2004;109(3):179-228. doi: 10.3109/2000-1967-084. Ups J Med Sci. 2004. PMID: 15508524 Review.

10

Angiogenesis and mast cells in Hodgkin lymphoma.

Glimelius I, Edström A, Fischer M, Nilsson G, Sundström C, Molin D, Amini RM, Enblad G. Glimelius I, et al. Among authors: molin d. Leukemia. 2005 Dec;19(12):2360-2. doi: 10.1038/sj.leu.2403992. Leukemia. 2005. PMID: 16224482 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results